[{"id":"9414e6bb-d90c-48a4-9277-b07aefc72016","acronym":"","url":"https://clinicaltrials.gov/study/NCT05341947","created_at":"2022-04-22T13:53:40.793Z","updated_at":"2024-07-02T16:36:11.600Z","phase":"Phase 1","brief_title":"Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma","source_id_and_acronym":"NCT05341947","lead_sponsor":"Jeremy Rudnick, M.D","biomarkers":" HER-2 • IL13RA2","pipe":" | ","alterations":" CD133 expression • HLA-A2 positive","tags":["HER-2 • IL13RA2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD133 expression • HLA-A2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KROS-201"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 06/01/2022","start_date":" 06/01/2022","primary_txt":" Primary completion: 06/01/2023","primary_completion_date":" 06/01/2023","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2022-04-22"}]